Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Century Therapeutics (IPSC) Earnings Date, Estimates & Call Transcripts

→ 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad)
Free IPSC Stock Alerts
$3.01
-0.12 (-3.83%)
(As of 05/17/2024 08:53 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(Mar. 14)
-$0.49 Beat By $0.07
Consensus EPS
(Mar. 14)
-$0.56
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

IPSC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IPSC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Century Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.62)($0.48)($0.55)
Q2 20242($0.64)($0.47)($0.56)
Q3 20242($0.66)($0.46)($0.56)
Q4 20242($0.69)($0.45)($0.57)
FY 20248($2.61)($1.86)($2.24)
Q1 20252($0.51)($0.48)($0.50)
Q2 20252($0.50)$0.46($0.02)
Q3 20252($0.53)$0.46($0.04)
Q4 20252($0.55)$0.47($0.04)
FY 20258($2.09)$0.91($0.59)

IPSC Earnings Date and Information

Century Therapeutics last issued its earnings data on March 14th, 2024. The reported ($0.49) EPS for the quarter, topping the consensus estimate of ($0.56) by $0.07. The company had revenue of $0.27 million for the quarter, compared to analyst estimates of $1.69 million. Century Therapeutics has generated ($2.21) earnings per share over the last year (($2.21) diluted earnings per share). Earnings for Century Therapeutics are expected to decrease in the coming year, from ($1.94) to ($1.97) per share. Century Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Century Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
Estimated)		------- 
3/14/2024Q4 2023($0.56)($0.49)+$0.07($0.33)$1.69 million$0.27 million
11/9/2023Q3 2023($0.53)($0.55)($0.02)($0.55)$1.08 million$0.15 million
8/9/2023Q2 2023($0.54)($0.56)($0.02)($0.56)$1.54 million$0.10 million
5/11/2023Q1 2023($0.53)($0.53)-($0.53)$2.26 million$1.72 million
3/16/2023Q4 2022($0.60)($0.55)+$0.05($0.55)$2.80 million$0.52 million
11/10/2022Q3 2022($0.59)($0.53)+$0.06($0.53)$1.57 million$2.22 million
Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
8/11/2022Q2 2022($0.50)($0.54)($0.04)($0.54)$1.20 million$1.40 million
5/16/2022Q1 2022($0.45)($0.66)($0.21)($0.66)$20.00 million$1.06 million
3/17/2022Q4 2021($0.46)($0.24)+$0.22($0.24)--
11/10/2021Q3 2021($0.40)($0.48)($0.08)($0.48)--
8/12/2021Q2 2021($0.40)($1.93)($1.53)($1.93)--

Century Therapeutics Earnings - Frequently Asked Questions

When is Century Therapeutics's earnings date?

Century Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on IPSC's earnings history.

Did Century Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Century Therapeutics (NASDAQ:IPSC) reported ($0.49) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.07. Learn more on analysts' earnings estimate vs. IPSC's actual earnings.

How much revenue does Century Therapeutics generate each year?

Century Therapeutics (NASDAQ:IPSC) has a recorded annual revenue of $2.23 million.

How much profit does Century Therapeutics generate each year?

Century Therapeutics (NASDAQ:IPSC) has a recorded net income of -$136.67 million. IPSC has generated -$2.21 earnings per share over the last four quarters.

What is Century Therapeutics's EPS forecast for next year?

Century Therapeutics's earnings are expected to decrease from ($1.94) per share to ($1.97) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:IPSC) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders